The agency crunched data from 26 randomized controlled trials, the gold standard in clinical tests, and decided they do not show an increased risk of heart attacks.
Read More...
Read the complete post at http://www.npr.org/blogs/health/2011/03/01/134174836/ziagen-fda-dispels-concerns-about-heart-attacks-for-abacavir?ft=1&f=103537970
Posted
Mar 02 2011, 06:47 AM
by
NPR Blogs: Shots - Health Blog